
In today's Pharmaceutical Executive Daily, Roche and Nurix Therapeutics announce a global collaboration, a pharma M&A roundup covers three deals announced today, and Pharmaceutical Executive contributors examine how an emerging wave of biologics is signaling a new treatment era in alopecia areata beyond the established JAK inhibitor class.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg

Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO

Pharmaceutical Executive Daily: China's Latest Policy Guidance

Pharmaceutical Executive Daily: Parabilis Medicines Prices Record-Breaking $670 Million IPO
Free AI-powered recaps of Pharmaceutical Executive and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.